Revumenib Monotherapy in Patients with Relapsed/Refractory KMT2Ar Acute Leukemias: Efficacy and Safety Results from the Augment-101 Phase 1/2 Study
Ibrahim Aldoss,Ghayas C. Issa,Michael J. Thirman,John DiPersio,Martha Arellano,James S. Blachly,Gabriel Mannis,Alexander Perl,David Dickens,Christine M. McMahon,Elie Traer,C. Michel Zwaan,Carolyn Grove,Richard Stone,Paul J. Shami, Ioannis Mantzaris,Matthew Greenwood,Neerav Shukla,Branko Cuglievan, Yu Gu, Rebecca G. Bagley, Kate Madigan, Soujanya Sunkaraneni, Huy Van Nguyen, Nicole McNeer, Eytan M. Stein BLOOD（2023）
AI 理解论文
溯源树
样例
